Pharmaceuticals market research reports by GlobalData

• Seasonal Influenza - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Seasonal Influenza - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Seasonal Influenza - Global Clinical Trials Review, 2024 provides an overview of Seasonal Influenza Clinical trials scenario. This report provides top line data relating to the clinical trials on Se ... Read More

• Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2024 provides an overview of Hemophilia A (Factor VIII Deficiency) Clinical trials scenario. This report pro ... Read More

• GW Pharmaceuticals Ltd - Strategic SWOT Analysis Review

  Feb 19, 2024  |  Published by: GlobalData  |  USD 125

  GW Pharmaceuticals Ltd - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a ... Read More

• Non-Small Cell Lung Cancer (NSCLC): Epidemiology Forecast to 2032

  Feb 16, 2024  |  Published by: GlobalData  |  USD 3,995

  Non-Small Cell Lung Cancer (NSCLC): Epidemiology Forecast to 2032 Summary Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of all lung cancer cases (National Cancer Institute, 2020). NSCLC begins when healthy cells that make up the lining of ... Read More

• DTx in Medical - Thematic Research

  Feb 15, 2024  |  Published by: GlobalData  |  USD 995

  DTx in Medical - Thematic Research Summary Digital therapeutics (DTx) are software-based interventions that deliver evidence-based therapeutic interventions to patients. The interventions are driven by high-quality software programs to prevent, manage, or treat a medical condition. DTx can be prescr ... Read More

• Retinol (Vitamin A) - Ingredient Insights

  Feb 12, 2024  |  Published by: GlobalData  |  USD 1,950

  Retinol (Vitamin A) - Ingredient Insights Summary This report explores the impact of retinol (vitamin A) across the FMCG space. Retinol is one of the most studied ingredients in personal care and has a plethora of health benefits, while it does pose risks when overused or used on premature skin. Sco ... Read More

• Premature Labor (PL) -Competitive Landscape

  Feb 12, 2024  |  Published by: GlobalData  |  USD 3,495

  Premature Labor (PL) -Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PL therapeutics. More than 5,000,000 total prevalent cases of PL are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology foreca ... Read More

• Ovarian Cancer Opportunity Assessment and Forecast

  Feb 08, 2024  |  Published by: GlobalData  |  USD 6,995

  Ovarian Cancer Opportunity Assessment and Forecast Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 7MM for marketed and late-stage pipeline therapies, with a launch date assessment by market for Ovarian Cancer. These sales fo ... Read More

• Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

  Jan 31, 2024  |  Published by: GlobalData  |  USD 7,500

  Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 Summary Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize qu ... Read More

• Pharma M&A Deals 2023 - Top Themes - Thematic Research

  Jan 30, 2024  |  Published by: GlobalData  |  USD 495

  Pharma M&A Deals 2023 - Top Themes - Thematic Research Summary This report analyzes the disruptive themes that have driven M&A activity in 2023 in the Pharma Sector The global pharma sector in 2023 witnessed deals worth $233 billion, a growth of 81% compared to 2022. In terms of deal volume also, th ... Read More

• Digital Marketing Trends in Psoriasis - January 2024

  Jan 30, 2024  |  Published by: GlobalData  |  USD 1,950

  Digital Marketing Trends in Psoriasis - January 2024 Summary AbbVie’s Skyrizi.com achieved the highest total traffic across branded PsO patient sites in the US, with almost three million visitors from January 2023 to December 2023. This was followed by Amgen’s Otezla.com (1.7 million visits). Overal ... Read More

• Idiopathic Pulmonary Fibrosis - Global Clinical Trials Review, 2024

  Jan 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Idiopathic Pulmonary Fibrosis - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Idiopathic Pulmonary Fibrosis - Global Clinical Trials Review, 2024 provides an overview of Idiopathic Pulmonary Fibrosis Clinical trials scenario. This report provides top line data rela ... Read More

• Glaucoma - Global Clinical Trials Review, 2024

  Jan 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Glaucoma - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Glaucoma - Global Clinical Trials Review, 2024 provides an overview of Glaucoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Glaucoma. Report includes an ove ... Read More

• Cervical Cancer - Global Clinical Trials Review, 2024

  Jan 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Cervical Cancer - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Cervical Cancer - Global Clinical Trials Review, 2024 provides an overview of Cervical Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical Ca ... Read More

• IgA Nephropathy (Berger's Disease) - Global Clinical Trials Review, 2024

  Jan 25, 2024  |  Published by: GlobalData  |  USD 2,500

  IgA Nephropathy (Berger's Disease) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “IgA Nephropathy (Berger's Disease) - Global Clinical Trials Review, 2024 provides an overview of IgA Nephropathy (Berger's Disease) Clinical trials scenario. This report provides top ... Read More

• Ankylosing Spondylitis (Bekhterev's Disease) - Global Clinical Trials Review, 2024

  Jan 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Ankylosing Spondylitis (Bekhterev's Disease) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Ankylosing Spondylitis (Bekhterev's Disease) - Global Clinical Trials Review, 2024 provides an overview of Ankylosing Spondylitis (Bekhterev's Disease) Clinical trials scen ... Read More

• Malaria - Global Clinical Trials Review, 2024

  Jan 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Malaria - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Malaria - Global Clinical Trials Review, 2024 provides an overview of Malaria Clinical trials scenario. This report provides top line data relating to the clinical trials on Malaria. Report includes an overvie ... Read More

• Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2024

  Jan 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2024 provides an overview of Post-Traumatic Stress Disorder (PTSD) Clinical trials scenario. This report pro ... Read More

• Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024

  Jan 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024 provides an overview of Lennox-Gastaut Syndrome Clinical trials scenario. This report provides top line data relating to the clinic ... Read More

• Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Global Clinical Trials Review, 2024

  Jan 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Global Clinical Trials Review, 2024 provides an overview of Methicillin-Resistant Staphyloc ... Read More

• Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2024

  Jan 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2024 provides an overview of Duchenne Muscular Dystrophy Clinical trials scenario. This report provides top line data relating t ... Read More

• Mitsubishi Tanabe Pharma Corp - Strategic SWOT Analysis Review

  Jan 23, 2024  |  Published by: GlobalData  |  USD 125

  Mitsubishi Tanabe Pharma Corp - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro ... Read More

• Meal Replacement Sports and Energy Products - Fad or Trend?

  Jan 14, 2024  |  Published by: GlobalData  |  USD 1,950

  Meal Replacement Sports and Energy Products - Fad or Trend? Summary This report explores the rise of meal replacement products, and implications for brands in the sector. Meal replacement products have proliferated in recent years, as consumers have increasingly sought convenient but healthy on-the- ... Read More

• Clinical Trials - What to Expect in 2024 - A Preview of Trials Planned to Initiate and Estimated to Complete

  Jan 09, 2024  |  Published by: GlobalData  |  USD 695

  Clinical Trials - What to Expect in 2024 - A Preview of Trials Planned to Initiate and Estimated to Complete Summary This report provides a preview of clinical trials that are planned to be initiated and projected to be completed in 2024. Scope The clinical trials data used for these analyses were e ... Read More

• Hyperinsulinemia (HI) - Competitive Landscape

  Jan 08, 2024  |  Published by: GlobalData  |  USD 3,495

  Hyperinsulinemia (HI) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in HI therapeutics. More than 1.07 billion prevalent cases of HI are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecas ... Read More

< prev 13 14 15 16 17 18 19 20 21 22 next >